These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 15284888
21. Characterization of two proteins of Staphylococcus aureus isolated from bovine clinical mastitis with homology to glyceraldehyde-3-phosphate dehydrogenase. Goji N, Potter AA, Perez-Casal J. Vet Microbiol; 2004 Apr 19; 99(3-4):269-79. PubMed ID: 15066729 [Abstract] [Full Text] [Related]
24. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis. Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA. Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):85-97. PubMed ID: 16165220 [Abstract] [Full Text] [Related]
25. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle. Chang BS, Moon JS, Kang HM, Kim YI, Lee HK, Kim JD, Lee BS, Koo HC, Park YH. Vaccine; 2008 Apr 16; 26(17):2081-91. PubMed ID: 18387721 [Abstract] [Full Text] [Related]
26. Protective effect of anti-SUAM antibodies on Streptococcus uberis mastitis. Almeida RA, Kerro-Dego O, Prado ME, Headrick SI, Lewis MJ, Siebert LJ, Pighetti GM, Oliver SP. Vet Res; 2015 Nov 19; 46():133. PubMed ID: 26582308 [Abstract] [Full Text] [Related]
28. Identification of a conserved B-cell epitope on the GapC protein of Streptococcus dysgalactiae. Zhang L, Zhou X, Fan Z, Tang W, Chen L, Dai J, Wei Y, Zhang J, Yang X, Yang X, Liu D, Yu L, Zhang H, Wu Z, Yu Y, Sun H, Cui Y. Microb Pathog; 2015 Nov 19; 83-84():23-8. PubMed ID: 25936577 [Abstract] [Full Text] [Related]
34. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats. Liu GX, Xu QA, Jin J, Li YH, Jia R, Guo JH, Fan MW. Vaccine; 2009 May 14; 27(22):2940-7. PubMed ID: 19428904 [Abstract] [Full Text] [Related]
36. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. Olive C, Sun HK, Ho MF, Dyer J, Horváth A, Toth I, Good MF. J Infect Dis; 2006 Aug 01; 194(3):316-24. PubMed ID: 16826479 [Abstract] [Full Text] [Related]
37. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S. BMC Microbiol; 2006 Aug 09; 6():71. PubMed ID: 16895610 [Abstract] [Full Text] [Related]
38. Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice. Okamoto S, Tamura Y, Terao Y, Hamada S, Kawabata S. Vaccine; 2005 Sep 23; 23(40):4852-9. PubMed ID: 15990202 [Abstract] [Full Text] [Related]